These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
¨
|
Annual
Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
|
x
|
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
|
Cayman
Islands
|
N/A
|
|
|
(State
or Other Jurisdiction of
|
(I.R.S.
Employer
|
|
|
Incorporation
or Organization)
|
Identification
No.)
|
|
13/F
Tower 2
|
|
New
World Tower
|
|
18
Queens Road Central
|
|
Hong
Kong
|
|
(Address
of Principal Executive Offices including Zip Code)
|
|
852-2801-5383
|
|
(Registrant’s
Telephone Number, Including Area
Code)
|
|
Common
Stock, $0.001 par value
|
|
(Title
of Class)
|
|
Common
Stock Purchase Warrants
|
|
(Title
of Class)
|
|
Units
consisting of one share of Common Stock and one
Common
Stock Purchase Warrant
|
|
(Title
of Class)
|
|
Large
Accelerated filer
¨
|
Accelerated
filer
¨
|
Non-accelerated
filer
¨
|
Smaller
reporting company
x
|
|
|
Page
|
|
|
Part
I.
|
3
|
|
|
Item
1. Business
|
3
|
|
|
Item
1A. Risk Factors
|
7
|
|
|
Item
1B. Unresolved Staff Comments
|
8
|
|
|
Item
2. Properties
|
8
|
|
|
Item
3. Legal Proceedings
|
8
|
|
|
Item
4. Submission of Matters to a Vote of Security Holders
|
8
|
|
|
Part
II.
|
9
|
|
|
Item
5. Market for Common Equity, Related Shareholder Matters and Issuer
Purchases of Equity Securities.
|
9
|
|
|
Item
6. Selected Financial Data
|
11
|
|
|
Item
7. Management Discussion and Analysis of Financial Condition and Results
of Operations
|
12
|
|
|
Item
7A. Quantative and Qualative Disclosures About Market Risk
|
14
|
|
|
Item
8. Financial Statements and Supplemental Data
|
14
|
|
|
Item
9. Changes in and Disagreements with Accountants on Accounting and
Financial Disclosure
|
14
|
|
|
Item
9A(T). Controls and Procedures
|
15
|
|
|
Item
9B. Other Information
|
15
|
|
|
Part
III
|
16
|
|
|
Item
10. Directors, Executive Officers, and Corporate
Governance
|
16
|
|
|
Item
11. Executive Compensation
|
18
|
|
|
Item
12. Security Ownership of Certain Beneficial Owners and Management and
Related Shareholder Matters
|
18
|
|
|
Item
13. Certain Relationships and Related Transactions, and Directors
Independence
|
20
|
|
|
Item
14. Principal Accountant Fees and Services
|
22
|
|
|
Part
IV
|
24
|
|
|
Item
15. Exhibits and Financial Statement Schedules
|
24
|
|
|
SIGNATURES
|
25
|
|
|
|
§
|
prolonged
economic expansion within China, including gross domestic product growth
of approximately 16.5% on average over the last 25 years, including 17.7%
in 2004, 15.0% in 2005 and 14.7% in 2006 (National Bureau of Statistics of
China) (China Statistical Yearbook – 2007,
http://www.stats.gov.cn/tjsj/ndsj/2007/indexeh.htm, viewed February 24,
2009);
|
|
|
§
|
increased
government focus within China on privatizing assets, improving foreign
trade and encouraging business and economic
activity;
|
|
|
§
|
the
recent entry of China into the World Trade Organization, the sole global
international organization dealing with the rules of trade between
nations, which may lead to a reduction on tariffs for industrial products,
a reduction in trade restrictions and an increase in trading with the
United States.
|
|
|
§
|
our
obligation to seek shareholder approval of our initial business
combination or obtain necessary financial information may delay the
consummation of a transaction;
|
|
|
§
|
our
obligation to redeem for cash ordinary shares held by our public
shareholders who vote against the business combination and exercise their
redemption rights may reduce the resources available to us for a business
combination;
|
|
|
§
|
our
outstanding warrants, and the future dilution they potentially represent,
may not be viewed favorably by certain target businesses;
and
|
|
|
§
|
the
requirement to acquire an operating business that has a fair market value
equal to at least 80% of the balance of the trust account at the time of
the acquisition (excluding deferred underwriting discounts and commissions
of $1,187,004 and taxes payable) could require us to acquire the assets of
several operating businesses at the same time, all of which sales would be
contingent on the closings of the other sales, which could make it more
difficult to consummate the business
combination.
|
|
Units
|
Ordinary
Shares
|
Warrants
|
||||||||||||||||||||||
|
High
|
Low
|
High
|
Low
|
High
|
Low
|
|||||||||||||||||||
|
Third
Quarter of 2009
|
$ | 7.65 | $ | 7.52 | $ | 7.98 | $ | 7.58 | $ | 0.16 | $ | 0.11 | ||||||||||||
|
Second
Quarter of 2009
|
$ | 7.25 | $ | 7.25 | $ | 7.65 | $ | 7.35 | $ | 0.55 | $ | 0.05 | ||||||||||||
|
First
Quarter of 2009
|
$ | 7.90 | $ | 7.00 | $ | 7.49 | $ | 7.10 | $ | 0.20 | $ | 0.05 | ||||||||||||
|
Fourth
Quarter of 2008
|
$ | 7.15 | $ | 6.50 | $ | 7.00 | $ | 6.21 | $ | 0.42 | $ | 0.13 | ||||||||||||
|
Third
Quarter of 2008
|
$ | 7.90 | $ | 7.60 | $ | 7.37 | $ | 6.85 | $ | 0.73 | $ | 0.50 | ||||||||||||
|
Second
Quarter of 2008
|
$ | 7.90 | $ | 7.60 | $ | 7.16 | $ | 6.95 | $ | 0.85 | $ | 0.60 | ||||||||||||
|
First
Quarter of 2008
|
$ | 8.15 | $ | 7.85 | - | - | - | - | ||||||||||||||||
|
Name
|
Ordinary
Shares
|
Warrants
|
||||||
|
John
Wang
|
230,000 | 0 | ||||||
|
W.R.
Hambrecht + Co., LLC
(1)
|
178,275 | 25,000 | ||||||
|
Cannon
Family Irrevocable Trust
(2)
|
173,275 | 0 | ||||||
|
Robert
J. Eu
|
173,275 | 0 | ||||||
|
AEX
Enterprises Limited
(3)
|
88,333 | 0 | ||||||
|
Hambrecht
1980 Revocable Trust
(4)
|
88,333 | 441,667 | ||||||
|
Shea
Ventures LLC
(5)
|
88,333 | 441,667 | ||||||
|
Marbella
Capital Partners Ltd.
(6)
|
40,000 | 200,000 | ||||||
|
AEX
Capital, LLC
(7)
|
0 | 441,666 | ||||||
|
Total:
|
1,059,824 | 1,550,000 | ||||||
|
(1)
|
William
R. Hambrecht is the controlling person of W.R. Hambrecht + Co.,
LLC.
|
|
(2)
|
Mr.
Cannon is the sole Trustee of Cannon Family Irrevocable
Trust.
|
|
(3)
|
Elizabeth
B. Hambrecht, Robert Eu’s wife, and William R. Hambrecht control AEX
Enterprises Limited.
|
|
(4)
|
William
R. Hambrecht is the trustee of the Hambrecht 1980 Revocable
Trust.
|
|
(5)
|
Edmund
H. Shea Jr. is the controlling person of Shea Ventures
LLC.
|
|
(6)
|
John
Wang is the controlling person of Marbella Capital Partners
Ltd.
|
|
(7)
|
Elizabeth
B. Hambrecht, Robert Eu’s wife, and Robert J. Eu control AEX Capital,
LLC.
|
|
Name
|
Age
|
Position
|
||
|
John
Wang
|
39
|
Chief
Executive Officer, President and Director
|
||
|
Robert
J. Eu
|
46
|
Chairman
of the Board,
|
||
|
Hao
Wu
|
35
|
Chief
Financial Officer, Secretary and Director
|
||
|
Hong
Xiang Liu
|
44
|
Director
|
|
|
§
|
each
person known by us to be the beneficial owner of more than 5% of our
outstanding ordinary shares;
|
|
|
§
|
each
of our officers and directors; and
|
|
|
§
|
all
our officers and directors as a
group.
|
|
Number of Ordinary
|
Approx.
Percentage
|
|||||||
|
Shares
|
of Outstanding
|
|||||||
|
Name and Address of Beneficial Owner
(1)
|
Beneficially Owned
|
Ordinary Shares
|
||||||
|
John
Wang
(2)
|
270,000 | 5.1 | % | |||||
|
Robert
J. Eu
(3)
|
261,608 | 4.9 | % | |||||
|
Stephen
N. Cannon
(4)
|
173,275 | 3.3 | % | |||||
|
Hao
Wu
|
— | — | ||||||
|
Hong
Xiang Liu
|
— | — | ||||||
|
William
R. Hambrecht
(5)
|
354,941 | 6.7 | % | |||||
|
W.R.
Hambrecht + Co., LLC
(6)
|
178,275 | 3.4 | % | |||||
|
Shea
Ventures LLC
(7)
|
88,333 | 1.7 | % | |||||
|
Marbella
Capital Partners Ltd.
(8)
|
40,000 | * | ||||||
|
AEX
Enterprises Limited
(9)
|
88,333 | 1.7 | % | |||||
|
Hambrecht
1980 Revocable Trust
(10)
|
88,333 | 1.7 | % | |||||
|
Loeb
Arbitrage Management, LLC
(11)
|
483,872 | 9.13 | % | |||||
|
HBK
Investments L.P.
(12)
|
423,900 | 8.0 | % | |||||
|
Integrated
Core Strategies (US) LLC
(13)
|
520,500 | 9.8 | % | |||||
|
Genesis
Capital Advisors LLC.
(14)
|
367,500 | 6.9 | % | |||||
|
Number of Ordinary
|
Approx.
Percentage
|
|||||||
|
Shares
|
of Outstanding
|
|||||||
|
Name and Address of Beneficial Owner
(1)
|
Beneficially Owned
|
Ordinary Shares
|
||||||
|
Bulldog
Investors
(15)
|
300,000 | 5.7 | % | |||||
|
Yarika
Partners, L.P.
(16)
|
284,225 | 5.4 | % | |||||
|
All
directors and executive officer as a group
(4
individuals)
|
704,883 |
13.3
|
% | |||||
|
Name
|
Ordinary Shares
|
Warrants
|
||||||
|
John
Wang
|
230,000 | 0 | ||||||
|
W.R.
Hambrecht + Co., LLC
(1)
|
178,275 | 25,000 | ||||||
|
Cannon
Family Irrevocable Trust
(2)
|
173,275 | 0 | ||||||
|
Robert
J. Eu
|
173,275 | 0 | ||||||
|
AEX
Enterprises Limited
(3)
|
88,333 | 0 | ||||||
|
Hambrecht
1980 Revocable Trust
(4)
|
88,333 | 441,667 | ||||||
|
Shea
Ventures LLC
(5)
|
88,333 | 441,667 | ||||||
|
Marbella
Capital Partners Ltd.
(6)
|
40,000 | 200,000 | ||||||
|
AEX
Capital, LLC
(7)
|
0 | 441,666 | ||||||
|
Total:
|
1,059,824 | 1,550,000 | ||||||
|
(1)
|
William
R. Hambrecht is the controlling person of W.R. Hambrecht + Co.,
LLC.
|
|
(2)
|
Mr.
Cannon is the sole Trustee of Cannon Family Irrevocable
Trust.
|
|
(3)
|
Elizabeth
B. Hambrecht, Robert Eu’s wife, and William R. Hambrecht control AEX
Enterprises Limited.
|
|
(4)
|
William
R. Hambrecht is the trustee of the Hambrecht 1980 Revocable
Trust.
|
|
(5)
|
Edmund
H. Shea Jr. is the controlling person of Shea Ventures
LLC.
|
|
(6)
|
John
Wang is the controlling person of Marbella Capital Partners
Ltd.
|
|
(7)
|
Elizabeth
B. Hambrecht, Robert Eu’s wife, and Robert J. Eu control AEX Capital,
LLC.
|
|
(a)
|
(1)
|
Financial
Statements
|
|
(2)
|
Schedules
|
|
(b)
|
Exhibits
|
|
Exhibit No.
|
Description
|
|
|
3.1
|
Memorandum
of Association
(1)
|
|
|
3.2
|
Amended
and Restated Articles of Association
(1)
|
|
|
4.1
|
Specimen
Unit Certificate
(1)
|
|
|
4.2
|
Specimen
Common Share Certificate
(1)
|
|
|
4.3
|
Specimen
Public Warrant Certificate
(1)
|
|
|
4.4
|
Specimen
Private Warrant Certificate
(1)
|
|
|
4.5
|
Form
of Warrant Agreement between Continental Stock Transfer & Trust
Company and the Registrant
(1)
|
|
|
4.6
|
Form
of Unit Purchase Option
(1)
|
|
|
10.1
|
Form
of Letter Agreement by John Wang
(1)
|
|
|
10.2
|
Form
of Letter Agreement by Robert J. Eu
(1)
|
|
|
10.3
|
Form
of Letter Agreement by Stephen N. Cannon
(1)
|
|
|
10.4
|
Form
of Letter Agreement by Lee S. Ting
(1)
|
|
|
10.5
|
Form
of Letter Agreement by AEX Enterprises Limited
(1)
|
|
|
10.6
|
Form
of Letter Agreement by Feng Zhang
(1)
|
|
|
10.7
|
Investment
Management Trust Agreement between Continental Stock Transfer & Trust
Company and the Registrant
|
|
|
10.8
|
Form
of Securities Escrow Agreement between the Registrant, Continental Stock
Transfer & Trust Company, the founding shareholders and the
founders
(1)
|
|
|
10.9
|
Form
of Services Agreement between the Registrant and Hambrecht Eu Capital
Management LLC
(1)
|
|
|
10.10
|
Form
of Registration Rights Agreement among the Registrant, the founding
shareholders and the founders
(1)
|
|
|
10.11
|
Revolving
Credit Agreement between the Registrant and Robert Eu
(1)
|
|
|
10.12
|
Promissory
Note between Registrant and Robert Eu
(1)
|
|
|
10.13
|
Form
of Warrant Purchase Agreement between the Registrant and AEX Enterprises
Limited
(1)
|
|
|
10.14
|
Form
of Right of First Refusal Agreement between the Registrant, Marbella
Capital Partners and AEX Enterprises Limited
(1)
|
|
|
31.1
|
Certification
of the Chief Executive Officer (Principal Executive Officer) pursuant to
Rule 13a-14(a) of the Securities Exchange Act, as
amended
|
|
|
31.2
|
Certification
of the Chief Financial Officer (Principal Financial Officer) pursuant to
Rule 13a-14(a) of the Securities Exchange Act, as
amended
|
|
| 32.1 |
Certification
of the Chief Executive Officers pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
|
| 32.2 |
Certification
of the Chief Financial Officers pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
|
January
22, 2010
|
HAMBRECHT
ASIA ACQUISITION CORP.
|
||
|
By:
|
/s/
John
Wang
|
||
|
John
Wang
|
|||
|
Chief
Executive Officer, President and Director
|
|||
|
(Principal
Executive Officer)
|
|||
|
January
22, 2010
|
By:
|
/s/
Hao
Wu
|
|
|
Hao
Wu
|
|||
|
Chief
Financial Officer, Secretary and Director
|
|||
|
(Principal
Financial and Accounting Officer)
|
|
January
22, 2010
|
By:
|
/s/
John
Wang
|
|
|
John
Wang
|
|||
|
Chief
Executive Officer, President and
|
|||
|
Director
(Principal Executive Officer)
|
|||
|
January
22, 2010
|
By:
|
/s/
Robert
J. Eu
|
|
|
Robert
J. Eu
|
|||
|
Chairman
of Board
|
|||
|
January
22, 2010
|
By:
|
/s/
Hao
Wu
|
|
|
Hao
Wu
|
|||
|
Chief
Financial Officer, Secretary and Director
|
|||
|
(Principal
Financial and Accounting Officer)
|
|||
|
January
22, 2010
|
By:
|
/s/
Hong
Xiang Liu
|
|
|
Hong
Xiang Liu
|
|||
|
Director
|
|
Page
|
|
|
Report
of Independent Registered Public Accounting Firm
|
F-2
|
|
Financial
Statements:
|
|
|
Balance
Sheets
|
F-3
|
|
Statements
of Operations
|
F-4
|
|
Statements
of Shareholders’ Equity
|
F-5
|
|
Statements
of Cash Flows
|
F-6
|
|
Notes
to Financial Statements
|
F-7
|
|
June 30,2009
|
December 31, 2008
|
December 31, 2007
|
||||||||||
|
ASSETS
|
||||||||||||
|
Current
assets
|
||||||||||||
|
Cash
|
$ | 30,271 | $ | 100,312 | $ | 101,671 | ||||||
|
Prepaid
expenses
|
95,686 | 108,330 | 183,254 | |||||||||
|
Total
current assets
|
125,957 | 208,642 | 284,925 | |||||||||
|
Other
asset
|
— | |||||||||||
|
Investments
held in the trust account
|
33,838,155 | 33,798,651 | ||||||||||
|
Total
assets
|
$ | 33,964,112 | $ | 34,007,293 | $ | 284,925 | ||||||
|
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
||||||||||||
|
Current
liabilities
|
||||||||||||
|
Accrued
expenses
|
$ | 76,275 | $ | 31,780 | $ | — | ||||||
|
Note
payable, shareholder
|
281,661 | |||||||||||
| — | ||||||||||||
|
Total
current liabilities
|
76,275 | 31,780 | 281,661 | |||||||||
|
Long-term
liabilities
|
||||||||||||
|
Deferred
underwriting fees, net of $356,101 subject to
forfeiture
in the event of possible redemption
|
830,903 | 830,903 | — | |||||||||
|
Ordinary shares
, subject
to possible redemption, (1,271,788 shares at
redemption
value of $7.92 per share)
|
10,072,561 | 10,072,561 | — | |||||||||
|
Shareholders’
equity
|
||||||||||||
|
Ordinary
shares, $.001 par value, 50,000,000 shares authorized; 5,299,125,
5,299,125 and 1,150,000 shares issued and outstanding as of June 30, 2009,
December 31, 2008 and December 31, 2007 (which includes 1,271,788,
1,271,788 shares and 0 shares respectively subject to possible
redemption)
|
5,299 | 5,299 | 1,150 | |||||||||
|
Additional
paid-in capital
|
22,851,981 | 22,851,981 | 23,850 | |||||||||
|
Earnings
(deficit) accumulated during the development stage
|
127,093 | 214,769 | (21,736 | ) | ||||||||
|
Total
shareholders’ equity
|
22,984,373 | 23,072,049 | 3,264 | |||||||||
|
Total
liabilities and shareholders’ equity
|
$ | 33,964,112 | $ | 34,007,293 | $ | 284,925 | ||||||
|
For the Period
Ended June 30,
2009 (six
months)
|
For the Period
Ended June 30,
2008 (six
months)
(unaudited)
|
Period from July
18,2007
(inception) to
June 30,2009
|
For the Year
ended December
31,2008
|
Period from July
18, 2007 to
December
31,2007
|
||||||||||||||||
|
Revenues
|
$ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||
|
Formation
and administrative costs
|
184,870 | 156,683 | 473,993 | 267,387 | 21,736 | |||||||||||||||
|
Loss
from operations
|
(184,870 | ) | (156,683 | ) | (473,993 | ) | (267,387 | ) | (21,736 | ) | ||||||||||
|
Interest
income, net
|
97,193 | 168,133 | 601,085 | 503,892 | — | |||||||||||||||
|
Net
income (loss)
|
(87,677 | ) | 11,449 | 127,093 | 236,505 | (21,736 | ) | |||||||||||||
|
Weighted
average number of ordinary shares subject to possible
redemption, basic and diluted
|
1,271,788 | 808,223 | 793,378 | 1,037,742 | — | |||||||||||||||
|
Income
(loss) per ordinary share subject to possible redemption, basic and
diluted
|
$ | (0.07 | ) | $ | 0.01 | $ | 0.16 | $ | — | $ | — | |||||||||
|
Weighted
average number of ordinary shares outstanding (not subject to possible
redemption) , basic
|
4,027,337 | 3,789,581 | 3,085,775 | 3,503,402 | 1,150,000 | |||||||||||||||
|
Income
(loss) per ordinary share not subject to possible redemption,
basic
|
$ | (0.02 | ) | $ | 0.00 | $ | 0.04 | $ | 0.07 | $ | (0.02 | ) | ||||||||
|
Weighted
average number of ordinary shares outstanding (not subject to possible
redemption), diluted
|
4,027,337 | 5,164,193 | 4,267,656 | 5,213,337 | 1,150,000 | |||||||||||||||
|
Income
(loss) per ordinary share not subject to possible redemption,
diluted
|
$ | (0.02 | ) | $ | 0.00 | $ | 0.03 | $ | 0.05 | $ | (0.02 | ) | ||||||||
|
Ordinary
Shares
|
Earnings
|
|||||||||||||||||||
|
Shares
|
Amount
|
Additional
Paid-in
Capital
|
(Deficit)
Accumulated
During
the
Development
Stage
|
Total
Shareholders’
Equity
|
||||||||||||||||
|
Balances
at July 18, 2007
|
— | $ | — | $ | — | $ | — | $ | — | |||||||||||
|
Sale
of units issued to founders on July 18, 2007 at approximately $0.02 per
share
|
1,150,000 | 1,150 | 23,850 | 25,000 | ||||||||||||||||
|
Net
loss
|
(21,736 | ) | (21,736 | ) | ||||||||||||||||
|
Balances
at December 31, 2007
|
1,150,000 | $ | 1,150 | $ | 23,850 | $ | (21,736 | ) | $ | 3,264 | ||||||||||
|
Proceeds
from sale of warrants in a private placement to initial
shareholders
|
1,550,000 | 1,550,000 | ||||||||||||||||||
|
Sale
of 4,000,000 units at $8.00 per unit in the public offering,
net of underwriters’ discount and offering expenses (1,199,999 shares
subject to possible redemption)
|
4,000,000 | 4,000 | 29,550,348 | 29,554,348 | ||||||||||||||||
|
Sale
of 239,300 units at $8.00 per unit in the public offering from
partial exercise of underwriters’ overallotment option, net of
underwriters’ discount and offering expenses (71,789 shares subject to
possible redemption)
|
239,300 | 239 | 1,800,344 | 1,800,583 | ||||||||||||||||
|
Forfeiture
of founders shares from partial exercise of underwriters’ overallotment
option
|
(90,175 | ) | (90 | ) | (90 | ) | ||||||||||||||
|
Proceeds
subject to possible redemption of 1,271,788 shares at a redemption value
of $7.92 per share
|
(10,072,561 | ) | (10,072,561 | ) | ||||||||||||||||
|
Net
income
|
236,505 | 236,505 | ||||||||||||||||||
|
Balances
at December 31, 2008
|
5,299,125 | $ | 5,299 | $ | 22,851,981 | $ | 214,769 | $ | 23,072,049 | |||||||||||
|
Net
loss
|
(87,677 | ) | (87,677 | ) | ||||||||||||||||
|
Balances
at June 30, 2009
|
5,299,125 | $ | 5,299 | $ | 22,851,981 | $ | 127,093 | $ | 22,984,373 | |||||||||||
|
For the Period
Ended June 30, 2009 (six months) |
For the Period
Ended June 30, 2008 (six months)
(unaudited)
|
Period from July
18,2007 (inception) to June 30,2009 |
For the Year
ended December 31,2008 |
Period from July
18, 2007 to December 31,2007 |
||||||||||||||||
|
Cash
flows from operating activities:
|
||||||||||||||||||||
|
Net
income (loss)
|
$ | (87,677 | ) | $ | 11,449 | $ | 127,093 | $ | 236,505 | $ | (21,736 | ) | ||||||||
|
Adjustments
to reconcile net income (loss) to net cash provided by (used in) operating
activities:
|
||||||||||||||||||||
|
Change
in operating assets and liabilities:
|
||||||||||||||||||||
|
Accrued
expenses
|
44,494 | 94,063 | 76,275 | 31,780 | ||||||||||||||||
|
Prepaid
expenses and other current asset
|
12,644 | 49,922 | (95,686 | ) | (108,330 | ) | ||||||||||||||
|
Net
cash provided by (used in) operating activities
|
(30,538 | ) | 155,434 | 107,682 | 159,955 | (21,736 | ) | |||||||||||||
|
Cash
used in investing activities:
|
||||||||||||||||||||
|
Proceeds
from the public offering deposited in trust account
|
— | (33,527,400 | ) | (33,527,400 | ) | (33,527,400 | ) | — | ||||||||||||
|
Interest
income re-invested in trust account
|
(85,836 | ) | (173,102 | ) | (510,361 | ) | (510,361 | ) | — | |||||||||||
|
Redemption
from the trust account
|
46,332 | 65,709 | 285,442 | 239,110 | — | |||||||||||||||
|
Net
cash used in investing activities
|
(39,504 | ) | (33,634,793 | ) | (33,838,155 | ) | (33,798,651 | ) | — | |||||||||||
|
Cash
flows from financing activities:
|
||||||||||||||||||||
|
Proceeds
from sale of ordinary shares to founders
|
— | — | 25,000 | — | 25,000 | |||||||||||||||
|
Proceeds
from shareholder’s note payable
|
$ | — | $ | — | $ | 281,661 | $ | — | $ | 281,661 | ||||||||||
|
Proceeds
from warrants purchased in private placement
|
— | 1,550,000 | 1,550,000 | 1,550,000 | — | |||||||||||||||
|
Proceeds from
initial public offering
|
$ | — | $ | 32,000,000 | $ | 32,000,000 | $ | 32,000,000 | $ | — | ||||||||||
|
Proceeds
from exercise of underwriters overallotment option
|
— | 1,914,400 | 1,914,400 | 1,914,400 | — | |||||||||||||||
|
Repayment
of shareholder’s note payable
|
— | — | (281,661 | ) | (281,661 | ) | — | |||||||||||||
|
Payment
of underwriters’ fee and offering cost of initial public
offering
|
— | (1,728,656 | ) | (1,728,656 | ) | (1,545,402 | ) | (183,254 | ) | |||||||||||
|
Net
cash provided by financing activities
|
— | 33,454,083 | 33,760,744 | 33,637,337 | 123,407 | |||||||||||||||
|
Net
increase (decrease) in cash
|
(70,042 | ) | (25,276 | ) | 30,271 | (1,359 | ) | 101,671 | ||||||||||||
|
Cash
at beginning of the period
|
100,312 | 101,671 | — | 101,671 | — | |||||||||||||||
|
Cash
at end of the period
|
$ | 30,271 | $ | 76,395 | $ | 30,271 | $ | 100,312 | $ | 101,671 | ||||||||||
|
Supplemental
schedule of non-cash financing activities:
|
||||||||||||||||||||
|
Deferred
underwriting fees, net
|
$ | — | $ | 830,903 | $ | 830,903 | $ | 830,903 | $ | — | ||||||||||
|
Ordinary
shares subject to possible redemption
|
$ | — | $ | 10,072,561 | $ | 10,072,561 | $ | 10,072,561 | $ | — | ||||||||||
|
Description
|
June 30, 2009
|
Quoted Prices in
Active Markets
(Level 1)
|
Significant Other
Observable Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||||||
|
Assets:
|
|
|
||||||||||||||
|
Cash
equivalents
|
$ | 30,271 | $ | 30,271 | $ | — | $ | — | ||||||||
|
Cash
equivalents held in Trust Account
|
33,838,155 | 33,838,155 | — | — | ||||||||||||
|
Total
|
$ | 33,868,426 | $ | 33,868,426 | $ | — | $ | — | ||||||||
|
Description
|
December 31, 2008
|
Quoted Prices in
Active Markets
(Level 1)
|
Significant Other
Observable Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||||||
|
Assets:
|
||||||||||||||||
|
Cash
equivalents
|
$ | 100,312 | $ | 100,312 | $ | — | $ | — | ||||||||
|
Cash
equivalents held in Trust Account
|
33,798,651 | 33,798,651 | — | — | ||||||||||||
|
Total
|
$ | 33,898,963 | $ | 33,898,963 | $ | — | $ | — | ||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|